Trials / Completed
CompletedNCT02456454
Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
Placebo Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Nationwide Children's Hospital · Academic / Other
- Sex
- All
- Age
- 3 Years – 7 Years
- Healthy volunteers
- Not accepted
Summary
Controlled trial of the efficacy and safety of valproate, versus risperidone in children, ages 3-7 yr. with Bipolar I or II Disorder, mixed, manic or hypomanic episode.
Detailed description
The objective of this study was to study the efficacy and safety of valproate, versus risperidone in children, ages 3-7 yr. with Bipolar I or II Disorder, mixed, manic or hypomanic episode.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risperidone | Liquid risperidone |
| DRUG | Valproic Acid | Liquid valproic acid |
| DRUG | Placebo |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2015-05-28
- Last updated
- 2018-12-12
Source: ClinicalTrials.gov record NCT02456454. Inclusion in this directory is not an endorsement.